December 12, 2025 - 03:14

In early December 2025, Synchrony Financial announced the renewal of its long-standing residential HVAC financing partnership with Mitsubishi Electric Trane HVAC US LLC. The new multi-year agreement, effective October 1, 2025, marks a significant extension of a decade-long collaboration aimed at providing homeowners with customizable financing solutions for upgrading and maintaining energy-efficient heating and cooling systems.
This renewal highlights the strategic role of Synchrony’s embedded financing tools, which are designed to enhance contractor sales and meet the growing demand for energy-efficient home solutions. As homeowners increasingly seek ways to improve their comfort while reducing energy costs, the availability of tailored financing options becomes essential.
The partnership not only benefits homeowners looking to invest in sustainable technologies but also empowers contractors to offer competitive financing solutions, ultimately driving sales and fostering customer loyalty in a rapidly evolving market.
March 15, 2026 - 03:23
Audit finds strong oversight at Fort Worth Housing Finance Corp, flags minor control gapsA recent operational audit of the Fort Worth Housing Finance Corporation has concluded that the agency maintains strong overall oversight, though it identified a handful of minor internal control...
March 14, 2026 - 07:39
Nvidia GTC, Macy's earnings, FOMC meeting: What to WatchThe upcoming week presents a critical lineup of events for the financial markets, with major corporate developments and a key Federal Reserve meeting on the calendar. All eyes will be on the...
March 13, 2026 - 20:57
Richard Donoff Encourages Americans to Prioritize Long-Term Financial PreparednessIn a recent address, financial expert Richard Donoff emphasized the critical need for American families to shift their focus toward long-term financial preparedness. He advocates for a proactive...
March 13, 2026 - 04:55
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate UpdateCapricor Therapeutics has announced its financial results for the fourth quarter and full year 2025, alongside significant progress in its lead clinical program. The company`s Biologics License...